Stay updated on Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.

Latest updates to the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page
- Check2 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.2 to v3.8.0 on a page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedA banner announces NIH website transition updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check16 days agoChange DetectedThe site footer now identifies the release as v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe page remains a 403 Forbidden error page, with its footer revision label changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check44 days agoChange DetectedMajor cleanup in Study Documents: key PDFs (Statistical Analysis Plan, Study Protocol) were removed. A new Revision: v3.7.0 label was added to the page.SummaryDifference18%

- Check65 days agoChange DetectedAdded 2015 ( U.S. NIH Grant/Contract ) to the study identifier list and updated the site revision from v3.6.5 to v3.6.6 in the page footer.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.